Published in Am Heart J on October 01, 1993
High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail (2013) 1.70
Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med (2013) 1.16
Primary graft failure after heart transplantation. J Transplant (2011) 0.93
Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart (2006) 0.93
Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ (2015) 0.80
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension. Ethn Dis (2016) 0.75
Postoperative care of the transplanted patient. Curr Cardiol Rev (2011) 0.75
Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation. J Thorac Dis (2017) 0.75
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med (1996) 8.02
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation (1993) 3.31
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ (1998) 3.07
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Lessons learned in pediatric heart transplantation. Ann Thorac Surg (1989) 2.46
Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet (1993) 2.44
Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol (2001) 2.27
Cardiac transplantation with cyclosporin A and prednisone. Ann Surg (1982) 2.21
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg (1999) 2.08
Anatomical variations of internal jugular vein location: impact on central venous access. Crit Care Med (1991) 2.06
Blood usage in lung transplantation. Transfusion (1998) 2.06
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03
Augmentation mammaplasty associated with a severe systemic illness. Ann Plast Surg (1979) 1.96
Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg (1995) 1.92
Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation (2001) 1.91
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg (2001) 1.82
Minimally invasive coronary artery bypass grafting. Ann Thorac Surg (1996) 1.81
Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation (2000) 1.76
Estimated 10-year cardiovascular risk in a British population: results of a national screening project. Int J Clin Pract (2008) 1.75
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Randomized trial of thrombolysis versus heparin in unstable angina. Circulation (1992) 1.74
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation (1987) 1.71
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA (1999) 1.67
Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement. Transplant Proc (1984) 1.66
Isolation and characterization of a near-haploid human cell line. Exp Cell Res (1999) 1.66
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65
Traumatic aortic rupture: diagnosis and management. Ann Thorac Surg (1998) 1.64
Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant (1999) 1.63
Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med (1992) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Principles of multiple organ procurement from cadaver donors. Ann Surg (1983) 1.56
Health metrics improve childhood immunisation coverage in a rural population of Andhra Pradesh. Indian J Public Health (2009) 1.55
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg (1995) 1.54
Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation (1990) 1.52
Autonomic mechanisms in hemodynamic responses to isometric exercise. J Clin Invest (1974) 1.51
Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. Transplantation (1990) 1.51
Organ procurement for pulmonary transplantation. Ann Thorac Surg (1989) 1.49
Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg (2000) 1.48
Anastomotic pitfalls in lung transplantation. J Thorac Cardiovasc Surg (1994) 1.47
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol (1998) 1.46
Single- versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg (1998) 1.46
Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg (1997) 1.46
Endobronchial management of benign, malignant, and lung transplantation airway stenoses. Ann Thorac Surg (1995) 1.45
Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant (1992) 1.45
Cardiac tamponade: hemodynamic observations in man. Circulation (1978) 1.45
Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn (1994) 1.43
Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. J Heart Lung Transplant (1994) 1.43
Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43
Gout in the heart transplant recipient: physiologic puzzle and therapeutic challenge. Am J Med (1989) 1.42
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. Am J Transplant (2009) 1.41
Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg (1998) 1.41
Proteins of the respiratory tract after heart-lung transplantation. Transplantation (1989) 1.40
Direct correlation of external systolic time intervals with internal indices of left ventricular function in man. Circulation (1971) 1.40